BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peeters KC, Kattan MW, Hartgrink HH, Kranenbarg EK, Karpeh MS, Brennan MF, van de Velde CJ. Validation of a nomogram for predicting disease-specific survival after an R0 resection for gastric carcinoma. Cancer. 2005;103:702-707. [PMID: 15641033 DOI: 10.1002/cncr.20783] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Kim PS, Lee KM, Han DS, Yoo MW, Han HS, Yang HK, Bang HY. External Validation of a Gastric Cancer Nomogram Derived from a Large-volume Center Using Dataset from a Medium-volume Center. J Gastric Cancer 2017;17:204-11. [PMID: 28970950 DOI: 10.5230/jgc.2017.17.e21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
2 van de Velde CJ. Current role of surgery and multimodal treatment in localized gastric cancer. Ann Oncol 2008;19 Suppl 5:v93-8. [PMID: 18611909 DOI: 10.1093/annonc/mdn319] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
3 Kim ES, Ishwaran H, Blackstone E, Lauer MS. External Prognostic Validations and Comparisons of Age- and Gender-Adjusted Exercise Capacity Predictions. Journal of the American College of Cardiology 2007;50:1867-75. [DOI: 10.1016/j.jacc.2007.08.003] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 3.8] [Reference Citation Analysis]
4 Quadri HS, Smaglo BG, Morales SJ, Phillips AC, Martin AD, Chalhoub WM, Haddad NG, Unger KR, Levy AD, Al-Refaie WB. Gastric Adenocarcinoma: A Multimodal Approach.Front Surg. 2017;4:42. [PMID: 28824918 DOI: 10.3389/fsurg.2017.00042] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
5 Xu Y, Jiang T, Cui Y, Zhao Y, Qiu L. Prognostic value of ABO blood group in patients with gastric cancer. Journal of Surgical Research 2016;201:188-95. [DOI: 10.1016/j.jss.2015.10.039] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
6 Wierda WG, O'brien S, Wang X, Faderl S, Ferrajoli A, Do K, Cortes J, Thomas D, Garcia-manero G, Koller C, Beran M, Giles F, Ravandi F, Lerner S, Kantarjian H, Keating M. Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia. Blood 2007;109:4679-85. [DOI: 10.1182/blood-2005-12-051458] [Cited by in Crossref: 236] [Cited by in F6Publishing: 228] [Article Influence: 15.7] [Reference Citation Analysis]
7 van den Boorn HG, Engelhardt EG, van Kleef J, Sprangers MAG, van Oijen MGH, Abu-Hanna A, Zwinderman AH, Coupé VMH, van Laarhoven HWM. Prediction models for patients with esophageal or gastric cancer: A systematic review and meta-analysis. PLoS One 2018;13:e0192310. [PMID: 29420636 DOI: 10.1371/journal.pone.0192310] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
8 Büchler MW, Kleeff J, Friess H. Surgical treatment of pancreatic cancer. J Am Coll Surg 2007;205:S81-6. [PMID: 17916525 DOI: 10.1016/j.jamcollsurg.2007.06.332] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
9 Dikken JL, van de Velde CJ, Gönen M, Verheij M, Brennan MF, Coit DG. The New American Joint Committee on Cancer/International Union Against Cancer staging system for adenocarcinoma of the stomach: increased complexity without clear improvement in predictive accuracy. Ann Surg Oncol. 2012;19:2443-2451. [PMID: 22618718 DOI: 10.1245/s10434-012-2403-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
10 Dikken JL, Baser RE, Gonen M, Kattan MW, Shah MA, Verheij M, van de Velde CJ, Brennan MF, Coit DG. Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer. Ann Surg Oncol. 2013;20:1623-1630. [PMID: 23143591 DOI: 10.1245/s10434-012-2723-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
11 Strong VE, Song KY, Park CH, Jacks LM, Gonen M, Shah M, Coit DG, Brennan MF. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg 2010;251:640-6. [PMID: 20224369 DOI: 10.1097/SLA.0b013e3181d3d29b] [Cited by in Crossref: 227] [Cited by in F6Publishing: 129] [Article Influence: 18.9] [Reference Citation Analysis]
12 Lagarde SM, ten Kate FJ, Reitsma JB, Busch OR, van Lanschot JJ. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol. 2006;24:4347-4355. [PMID: 16963732 DOI: 10.1200/jco.2005.04.9445] [Cited by in Crossref: 91] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
13 Li Z, Wu X, Gao X, Shan F, Ying X, Zhang Y, Ji J. Development and validation of an artificial neural network prognostic model after gastrectomy for gastric carcinoma: An international multicenter cohort study. Cancer Med. 2020;9:6205-6215. [PMID: 32666682 DOI: 10.1002/cam4.3245] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
14 Jansen EP, Boot H, Verheij M, van de Velde CJ. Optimal locoregional treatment in gastric cancer. J Clin Oncol. 2005;23:4509-4517. [PMID: 16002841 DOI: 10.1200/JCO.2005.21.196] [Cited by in Crossref: 70] [Cited by in F6Publishing: 18] [Article Influence: 4.1] [Reference Citation Analysis]
15 Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17:3077-3079. [PMID: 20882416 DOI: 10.1245/s10434-010-1362-z] [Cited by in Crossref: 653] [Cited by in F6Publishing: 679] [Article Influence: 59.4] [Reference Citation Analysis]
16 Oñate-Ocaña LF, Aiello-Crocifoglio V, Gallardo-Rincón D, Herrera-Goepfert R, Brom-Valladares R, Carrillo JF, Cervera E, Mohar-Betancourt A. Serum albumin as a significant prognostic factor for patients with gastric carcinoma. Ann Surg Oncol 2007;14:381-9. [PMID: 17160496 DOI: 10.1245/s10434-006-9093-x] [Cited by in Crossref: 111] [Cited by in F6Publishing: 110] [Article Influence: 6.9] [Reference Citation Analysis]
17 Koc M, Dizen H, Ozalp N, Keskek M, Karakose N, Tez M. External validation of a US-derived nomogram that predicts individual survival after gastric cancer resection. Langenbecks Arch Surg 2009;394:755-6. [DOI: 10.1007/s00423-008-0426-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
18 Dikken JL, Coit DG, Baser RE, Gönen M, Goodman KA, Brennan MF, Jansen EP, Boot H, van de Velde CJ, Cats A, Verheij M. Performance of a nomogram predicting disease-specific survival after an R0 resection for gastric cancer in patients receiving postoperative chemoradiation therapy. Int J Radiat Oncol Biol Phys 2014;88:624-9. [PMID: 24411620 DOI: 10.1016/j.ijrobp.2013.11.213] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
19 Lewis RS Jr, Vollmer CM Jr. Risk scores and prognostic models in surgery: pancreas resection as a paradigm. Curr Probl Surg 2012;49:731-95. [PMID: 23131540 DOI: 10.1067/j.cpsurg.2012.08.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
20 Coit D. Adjuvant Therapy for Gastric Cancer. Journal of the American College of Surgeons 2007;205:S54-8. [DOI: 10.1016/j.jamcollsurg.2007.06.329] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
21 Knab LM, Belotte J, Munshi HG, Bentrem DJ. Comparative Effectiveness in Esophagogastric Cancer. In: Bilimoria KY, Minami CA, Mahvi DM, editors. Comparative Effectiveness in Surgical Oncology. Cham: Springer International Publishing; 2015. pp. 121-42. [DOI: 10.1007/978-3-319-12553-4_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Lee CM, Jee YS, Lee JH, Son SY, Ahn SH, Park DJ, Kim HH. Length of negative resection margin does not affect local recurrence and survival in the patients with gastric cancer. World J Gastroenterol 2014; 20(30): 10518-10524 [PMID: 25132770 DOI: 10.3748/wjg.v20.i30.10518] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
23 Chen S, Chen X, Nie R, Ou Yang L, Liu A, Li Y, Zhou Z, Chen Y, Peng J. A nomogram to predict prognosis for gastric cancer with peritoneal dissemination. Chin J Cancer Res 2018;30:449-59. [PMID: 30210225 DOI: 10.21147/j.issn.1000-9604.2018.04.08] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
24 Reim D, Novotny A, Eom BW, Park Y, Yoon HM, Choi IIJ, Kim YW, Nam BH, Ryu KW. External Validation of an Eastern Asian Nomogram for Survival Prediction After Gastric Cancer Surgery in a European Patient Cohort. Medicine (Baltimore) 2015;94:e2406. [PMID: 26717397 DOI: 10.1097/MD.0000000000002406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
25 Eom BW, Ryu KW, Nam BH, Park Y, Lee HJ, Kim MC, Cho GS, Kim CY, Ryu SW, Shin DW, Hyung WJ, Lee JH. Survival nomogram for curatively resected Korean gastric cancer patients: multicenter retrospective analysis with external validation. PLoS One 2015;10:e0119671. [PMID: 25723182 DOI: 10.1371/journal.pone.0119671] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
26 Ashfaq A, Kidwell JT, McGhan LJ, Dueck AC, Pockaj BA, Gray RJ, Bagaria SP, Wasif N. Validation of a gastric cancer nomogram using a cancer registry. J Surg Oncol 2015;112:377-80. [PMID: 26271201 DOI: 10.1002/jso.23999] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
27 Gold JS, Gönen M, Gutiérrez A, Broto JM, García-del-Muro X, Smyrk TC, Maki RG, Singer S, Brennan MF, Antonescu CR, Donohue JH, DeMatteo RP. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol 2009;10:1045-52. [PMID: 19793678 DOI: 10.1016/S1470-2045(09)70242-6] [Cited by in Crossref: 291] [Cited by in F6Publishing: 143] [Article Influence: 22.4] [Reference Citation Analysis]
28 Zhou ML, Wang L, Wang JZ, Yang W, Hu R, Li GC, Sheng WQ, Zhang Z. Validation of the Memorial Sloan Kettering Cancer Center nomogram to predict disease-specific survival in a Chinese gastric cancer population receiving postoperative chemoradiotherapy after an R0 resection. Oncotarget 2016;7:64757-65. [PMID: 27588465 DOI: 10.18632/oncotarget.11665] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
29 Lee SE, Ryu KW, Nam BH, Lee JH, Choi IJ, Kook M, Park SR, Kim Y. Prognostic Significance of Intraoperatively Estimated Surgical Stage in Curatively Resected Gastric Cancer Patients. Journal of the American College of Surgeons 2009;209:461-7. [DOI: 10.1016/j.jamcollsurg.2009.06.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
30 Smyth EC, Fassan M, Cunningham D, Allum WH, Okines AF, Lampis A, Hahne JC, Rugge M, Peckitt C, Nankivell M, Langley R, Ghidini M, Braconi C, Wotherspoon A, Grabsch HI, Valeri N. Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial. J Clin Oncol. 2016;34:2721-2727. [PMID: 27298411 DOI: 10.1200/jco.2015.65.7692] [Cited by in Crossref: 115] [Cited by in F6Publishing: 65] [Article Influence: 19.2] [Reference Citation Analysis]
31 Lee CM, Cho JM, Jang YJ, Park SS, Park SH, Kim SJ, Mok YJ, Kim CS, Kim JH. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer. Ann Surg Oncol 2015;22:765-71. [PMID: 25201506 DOI: 10.1245/s10434-014-4073-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
32 Wong J, Rahman S, Saeed N, Lin HY, Almhanna K, Shridhar R, Hoffe S, Meredith KL. Prognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experience. J Gastrointest Surg. 2013;17:2059-2066. [PMID: 24129828 DOI: 10.1007/s11605-013-2380-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
33 Woo Y, Son T, Song K, Okumura N, Hu Y, Cho GS, Kim JW, Choi SH, Noh SH, Hyung WJ. A Novel Prediction Model of Prognosis After Gastrectomy for Gastric Carcinoma: Development and Validation Using Asian Databases. Ann Surg. 2016;264:114-120. [PMID: 26945155 DOI: 10.1097/sla.0000000000001523] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
34 Karakiewicz PI, Suardi N, Capitanio U, Isbarn H, Jeldres C, Perrotte P, Sun M, Ficarra V, Zigeuner R, Tostain J, Mejean A, Cindolo L, Pantuck AJ, Belldegrun AS, Zini L, de la Taille A, Chautard D, Descotes J, Shariat SF, Valeri A, Mulders PF, Lang H, Lechevallier E, Patard J. Conditional Survival Predictions After Nephrectomy for Renal Cell Carcinoma. Journal of Urology 2009;182:2607-12. [DOI: 10.1016/j.juro.2009.08.084] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
35 Shim JH, Song KY, Jeon HM, Park CH, Jacks LM, Gonen M, Shah MA, Brennan MF, Coit DG, Strong VE. Is gastric cancer different in Korea and the United States? Ann Surg Oncol. 2014;21:2332-2339. [PMID: 24599411 DOI: 10.1245/s10434-014-3608-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
36 Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage. Ann Surg Oncol. 2007;14:317-328. [PMID: 17094022 DOI: 10.1245/s10434-006-9218-2] [Cited by in Crossref: 155] [Cited by in F6Publishing: 161] [Article Influence: 9.7] [Reference Citation Analysis]
37 Yuan SQ, Wu WJ, Qiu MZ, Wang ZX, Yang LP, Jin Y, Yun JP, Gao YH, Li YH, Zhou ZW, Wang F, Xu RH. Development and Validation of a Nomogram to Predict the Benefit of Adjuvant Radiotherapy for Patients with Resected Gastric Cancer. J Cancer 2017;8:3498-505. [PMID: 29151934 DOI: 10.7150/jca.19879] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
38 Zhang Y, Chen XL, Chen WM, Zhou HB. Prognostic Nomogram for the Overall Survival of Patients with Newly Diagnosed Multiple Myeloma. Biomed Res Int 2019;2019:5652935. [PMID: 31080823 DOI: 10.1155/2019/5652935] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
39 Bria E, De Manzoni G, Beghelli S, Tomezzoli A, Barbi S, Di Gregorio C, Scardoni M, Amato E, Frizziero M, Sperduti I, Corbo V, Brunelli M, Bersani S, Tortora G, Scarpa A. A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status. Ann Oncol. 2013;24:693-701. [PMID: 23131390 DOI: 10.1093/annonc/mds506] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 4.0] [Reference Citation Analysis]
40 Akl A, Ismail AM, Ghoneim M. Prediction of graft survival of living-donor kidney transplantation: nomograms or artificial neural networks? Transplantation. 2008;86:1401-1406. [PMID: 19034010 DOI: 10.1097/tp.0b013e31818b221f] [Cited by in Crossref: 38] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
41 Han DS, Suh YS, Kong SH, Lee HJ, Choi Y, Aikou S, Sano T, Park BJ, Kim WH, Yang HK. Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer. J Clin Oncol. 2012;30:3834-3840. [PMID: 23008291 DOI: 10.1200/jco.2012.41.8343] [Cited by in Crossref: 179] [Cited by in F6Publishing: 117] [Article Influence: 17.9] [Reference Citation Analysis]
42 Lagarde SM, Reitsma JB, de Castro SMM, ten Kate FJW, Busch ORC, van Lanschot JJB. Prognostic nomogram for patients undergoing oesophagectomy for adenocarcinoma of the oesophagus or gastro-oesophageal junction. British Journal of Surgery 2007;94:1361-8. [DOI: 10.1002/bjs.5832] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
43 Van Cutsem E, Dicato M, Arber N, Benson A, Cunningham D, Diaz-Rubio E, Glimelius B, Goldberg R, Haller D, Haustermans K, Koo-Kang Y, Labianca R, Lang I, Minsky B, Nordlinger B, Roth A, Rougier P, Schmoll HJ, Sobrero A, Tabernero J, Szawlowski A, van de Velde C. The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005. Ann Oncol 2006;17 Suppl 6:vi13-8. [PMID: 16809641 DOI: 10.1093/annonc/mdl976] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
44 Gross ND, Patel SG, Carvalho AL, Chu PY, Kowalski LP, Boyle JO, Shah JP, Kattan MW. Nomogram for deciding adjuvant treatment after surgery for oral cavity squamous cell carcinoma. Head Neck 2008;30:1352-60. [PMID: 18720518 DOI: 10.1002/hed.20879] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
45 Chen D, Jiang B, Xing J, Liu M, Cui M, Liu Y, Wang Z, Chen L, Yang H, Zhang C, Yao Z, Zhang N, Ji J, Qu H, Su X. Validation of the memorial Sloan-Kettering Cancer Center nomogram to predict disease-specific survival after R0 resection in a Chinese gastric cancer population. PLoS One 2013;8:e76041. [PMID: 24146811 DOI: 10.1371/journal.pone.0076041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
46 Jelovsek JE, Piccorelli A, Barber MD, Tunitsky-bitton E, Kattan MW. Prediction Models for Postpartum Urinary and Fecal Incontinence in Primiparous Women. Female Pelvic Medicine & Reconstructive Surgery 2013;19:110-8. [DOI: 10.1097/spv.0b013e31828508f0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
47 Högner A, Al-Batran SE, Siveke JT, Lorenz M, Bartels P, Breithaupt K, Malfertheiner P, Homann N, Stein A, Gläser D, Tamm I, Hinke A, Vogel A, Thuss-Patience P; PaFLO investigators. Pazopanib with 5-FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase-II study-The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO-STO-0510. Int J Cancer 2021. [PMID: 34741530 DOI: 10.1002/ijc.33864] [Reference Citation Analysis]
48 Brisinda G, Crocco A, Tomaiuolo P, Santullo F, Mazzari A, Vanella S. Extended or limited lymph node dissection? A gastric cancer surgical dilemma. Ann Surg 2012;256:e30-1. [PMID: 23108130 DOI: 10.1097/SLA.0b013e31827693c3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
49 Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW, Coit DG, Brennan MF. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome. Ann Surg. 2007;246:1-8. [PMID: 17592282 DOI: 10.1097/01.sla.0000255563.65157.d2] [Cited by in Crossref: 151] [Cited by in F6Publishing: 136] [Article Influence: 10.1] [Reference Citation Analysis]
50 Schmidt B, Yoon SS. D1 versus D2 lymphadenectomy for gastric cancer. J Surg Oncol. 2013;107:259-264. [PMID: 22513454 DOI: 10.1002/jso.23127] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 4.6] [Reference Citation Analysis]
51 Yen M, Twu N, Lai C, Horng H, Chao K, Juang C. Importance of delivered cycles and nomogram for intraperitoneal chemotherapy in ovarian cancer. Gynecologic Oncology 2009;114:415-9. [DOI: 10.1016/j.ygyno.2009.05.034] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
52 Patel SG, Lydiatt WM. Staging of head and neck cancers: Is it time to change the balance between the ideal and the practical?: Staging of Head and Neck Cancer. J Surg Oncol 2008;97:653-7. [DOI: 10.1002/jso.21021] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
53 Gold JS, Tang LH, Gönen M, Coit DG, Brennan MF, Allen PJ. Utility of a Prognostic Nomogram Designed for Gastric Cancer in Predicting Outcome of Patients with R0 Resected Duodenal Adenocarcinoma. Ann Surg Oncol 2007;14:3159-67. [DOI: 10.1245/s10434-007-9542-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
54 Gee DW, Rattner DW. Management of gastroesophageal tumors. Oncologist. 2007;12:175-185. [PMID: 17296813 DOI: 10.1634/theoncologist.12-2-175] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
55 Akgül Ö, Ocak S, Gündoğdu SB, Yalaza M, Güldoğan CE, Tez M. Comparison of East and West Survival Nomograms in Turkish Gastric Cancer Patients Who Underwent Radical Surgery. Scand J Surg 2018;107:308-14. [PMID: 29637843 DOI: 10.1177/1457496918766724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. The Lancet Oncology 2010;11:439-49. [DOI: 10.1016/s1470-2045(10)70070-x] [Cited by in Crossref: 1005] [Cited by in F6Publishing: 509] [Article Influence: 83.8] [Reference Citation Analysis]
57 Strong VE, Song KY, Park CH, Jacks LM, Gonen M, Shah MA, Coit DG, Brennan MF. Comparison of disease-specific survival in the United States and Korea after resection for early-stage node-negative gastric carcinoma. J Surg Oncol. 2013;107:634-640. [PMID: 23192297 DOI: 10.1002/jso.23288] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
58 Brenner B, Hoshen MB, Purim O, David MB, Ashkenazi K, Marshak G, Kundel Y, Brenner R, Morgenstern S, Halpern M, Rosenfeld N, Chajut A, Niv Y, Kushnir M. MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol 2011; 17(35): 3976-3985 [PMID: 22046085 DOI: 10.3748/wjg.v17.i35.3976] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 62] [Article Influence: 6.1] [Reference Citation Analysis]
59 Coimbra FJF, de Jesus VHF, Franco CP, Calsavara VF, Ribeiro HSC, Diniz AL, de Godoy AL, de Farias IC, Riechelmann RP, Begnami MDFS, da Costa WL. Predicting overall and major postoperative morbidity in gastric cancer patients. J Surg Oncol. 2019;120:1371-1378. [PMID: 31696512 DOI: 10.1002/jso.25743] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
60 Das P, Ajani JA. Gastric and gastro-oesophageal cancer therapy. Expert Opin Pharmacother. 2005;6:2805-2812. [PMID: 16318431 DOI: 10.1517/14656566.6.16.2805] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
61 Vickers AJ, Cronin AM, Kattan MW, Gonen M, Scardino PT, Milowsky MI, Dalbagni G, Bochner BH; International Bladder Cancer Nomogram Consortium. Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach. Cancer 2009;115:5460-9. [PMID: 19823979 DOI: 10.1002/cncr.24615] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
62 Oh SE, Seo SW, Choi MG, Sohn TS, Bae JM, Kim S. Prediction of Overall Survival and Novel Classification of Patients with Gastric Cancer Using the Survival Recurrent Network. Ann Surg Oncol. 2018;25:1153-1159. [PMID: 29497908 DOI: 10.1245/s10434-018-6343-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
63 Songun I, van de Velde CJ. Optimal surgery for advanced gastric cancer. Expert Rev Anticancer Ther 2009;9:1849-58. [PMID: 19954295 DOI: 10.1586/era.09.132] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
64 Munene G, Francis W, Garland SN, Pelletier G, Mack LA, Bathe OF. The quality of life trajectory of resected gastric cancer. J Surg Oncol. 2012;105:337-341. [PMID: 22095440 DOI: 10.1002/jso.22139] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
65 Ma YQ, Wen Y, Liang H, Zhong JG, Pang PP. Magnetic resonance imaging-radiomics evaluation of response to chemotherapy for synchronous liver metastasis of colorectal cancer. World J Gastroenterol 2021; 27(38): 6465-6475 [PMID: 34720535 DOI: 10.3748/wjg.v27.i38.6465] [Reference Citation Analysis]
66 Marrelli D, Morgagni P, de Manzoni G, Marchet A, Baiocchi GL, Giacopuzzi S, Coniglio A, Mocellin S, Saragoni L, Roviello F. External Validation of a Score Predictive of Recurrence after Radical Surgery for Non-Cardia Gastric Cancer: Results of a Follow-Up Study. J Am Coll Surg. 2015;221:280-290. [PMID: 26141465 DOI: 10.1016/j.jamcollsurg.2015.03.042] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
67 Barchi LC, Yagi OK, Jacob CE, Mucerino DR, Ribeiro U, Marrelli D, Roviello F, Cecconello I, Zilberstein B. Predicting recurrence after curative resection for gastric cancer: External validation of the Italian Research Group for Gastric Cancer (GIRCG) prognostic scoring system. Eur J Surg Oncol. 2016;42:123-131. [PMID: 26365755 DOI: 10.1016/j.ejso.2015.08.164] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]